medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 01

<< Back Next >>

Ginecol Obstet Mex 2020; 88 (01)

Abnormal uterine bleeding and PALM COEIN

Sepúlveda-Agudelo J, Sepúlveda-Sanguino AJ
Full text How to cite this article

Language: Spanish
References: 58
Page: 59-67
PDF size: 244.76 Kb.


Key words:

Abnormal uterine bleeding, Language, Uterine diseases, Uterine hemorrhage, Cohort Studies.

ABSTRACT

Objective: To update the new terminology of abnormal uterine bleeding and the PALM COEIN classification
Method: Bibliographic search of articles published in English or Spanish with the keyword PALM COEIN. From the first article published in 2010 to 2018 in the MedLine, PubMed, Embase and Ovid databases.
Results: 64 articles were collected, but only 18 mentioned the term, 24 were repeated. 22 were selected that dealt with the subject under study and were referred to with the current classification, of these works 6 were cohort, 2 systematic review, 2 newsletters and 12 theme reviews.
Conclusion: This new terminology will facilitate understanding and communication, independent of language and culture, in addition to the most understandable approach with our patients. This classification of PALM COEIN facilitates the epidemiological, etiological investigation and treatment of patients with abnormal uterine bleeding.


REFERENCES

  1. Bandi ND, et al. Utility of the PALM-COEIN classification of abnormal uterine bleeding for Indian gynecologists. Int J Gynecol Obstet. 2016; 133: 196-98. doi: 10.1016/j. ijgo.2015.09.030

  2. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012

  3. Bahamondes L, Ali M. Recent advances in managing and understanding menstrual disorders. Prime Rep. 2015; 7: 33. doi:10.12703/P7-33

  4. Singh S, et al. Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can 2018; 40 (5): e391-e415. doi: 10.1016/j.jogc.2018.03.007

  5. Sepúlveda J, Díaz G. Detención de la hemorragia uterina anormal en pacientes a quienes se realizó histeroscopia operatoria. Ginecol Obstet Mex. 2018; 86 (1): 13-25. doi: 10.24245/gom.v86i1.1666

  6. Fraser IS, et al. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertility and Sterility. 2007; 87 (3): 466-76. doi:10.1016/j.fertnstert. 2007.01.023

  7. Fraser IS, et al. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding?. Human Reproduction 2007; 22: (3): 635-43. doi:10.1093/humrep/del478

  8. Woolcock JG, et al. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008; 90: 2269-80. doi: 10.1016/j.fertnstert.2007.10.060

  9. Bacon JL. Abnormal Uterine Bleeding: Current Classification and Clinical Management. Obstet Gynecol Clin North Am. 2017; 44 (2): 179-93. doi: 10.1016/j.ogc.2017.02.012

  10. Munro MG, et al. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them? Am J Obstet Gynecol. 2012; 207 (4): 259-65. doi: 10.1016/j.ajog.2012.01.046

  11. Munro MG. Abnormal uterine bleeding. Cambridge, UK: Cambridge University Press; 2010.

  12. Committee on Practice Bulletins-Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012; 120 (1): 197-206. doi: 10.1097/AOG.0b013e318262e320.

  13. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95: 2204-8. doi:10.1016/j.fertnstert. 2011.03.079

  14. Munro MG. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 3-22. doi: 10.1016/j.bpobgyn.2016.09.011

  15. American Association of Gynecologic Laparoscopists. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of Endometrial Polyps. J Minim Invasive Gynecol. 2012; 19 (1): 3-10. doi:10.1016/j. jmig.2011.09.003

  16. Vigueras A. Escalona JR. Pólipos endometriales: Actualización en diagnóstico y tratamiento. Rev Chil Obstet Ginecol 2016; 81 (2): 152-8.

  17. Clark TJ, Stevenson H. Endometrial polyps and abnormal uterine bleeding (AUB-P): What is the relationship, how are they diagnosed and how are they treated? Best Pract Res Obstet Gynaecol. 2017; 40: 89-104. doi: 10.1016/j. bpobgyn.2016.09.005

  18. Salim S, et al. Diagnosis and Management of Endometrial Polyps: A Critical Review of the Literature. J Minim Invasive Gynecol 2011; 18: 569-81. doi: 10.1016/j.jmig.2011.05.018.

  19. Beal HN, et al. Endometrial cells identified in cervical cytology in women > or 5 40 years of age: criteria for appropriate endometrial evaluation. Am J Obstet Gynecol 2007; 196: 568. e1-5. doi: 10.1016/j.ajog.2007.01.040

  20. Finco A, et al. Surgical management of abnormal uterine bleeding in fertile age women. Women’s Health (Lond). 2015; 11 (4): 513-25. doi: 10.2217/whe.15.12

  21. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand. 2010; 89: 992-1002. doi: 10.3109/00016349.2010.493196

  22. Deneris A. PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health. 2016; 61 (3): 376-9. doi:10.1111/jmwh.12440

  23. Munro MG, et al. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113: 3-13. doi:10.1016/j.ijgo.2010.11.011

  24. Hapangama DK, Bulmer JN. Pathophysiology of heavy menstrual bleeding. Women’s Health 2016; 12 (1): 3-13. doi: 10.2217/whe.15.81

  25. Donnez J, et al. Introduction: Uterine adenomyosis, another enigmatic disease of our time. Fertil Steril. 2018; 109 (3): 369-70. doi: 10.1016/j.fertnstert.2018.01.035.

  26. García-Solares J, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 2018; 109: 371-9. doi.org/10.1016/j.fertnstert.2017.12.030

  27. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 2017; 40: 68-81. doi:10.1016/j.bpobgyn.2016.09.006

  28. Gordts S, et al. Symptoms and classification of uterine adenomyosis. Fertil Steril 2018; 109: 380-8. doi.org/10.1016/j. fertnstert.2018.01.006

  29. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril 2018; 109: 389-97. doi. org/10.1016/j.fertnstert.2018.01.024

  30. Champaneria R, et al. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand 2010; 89: 1374-84. doi: 10.3109/00016349.2010.512061

  31. Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB). Best Pract Res Clin Obstet Gynaecol. 2017; 40: 82-88. doi: 10.1016/j. bpobgyn.2016.09.008

  32. Islam MS, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab. 2013; 98 (3): 921-34. doi: 10.1210/ jc.2012-3237

  33. Stewart EA, et al. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017; 124 (10): 1501-12. doi: 10.1111/1471-0528.14640

  34. Styer AK, Rueda BR. The epidemiology and genetics of uterine leiomyoma. Best Practice & Research Clinical Obstetrics and Gynaecology 2016; 34: 3-12. doi: 10.1016/j. bpobgyn.2015.11.018

  35. Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 54-65. doi: 10.1016/j.bpobgyn.2015.11.012.

  36. Sepúlveda J, Alarcón MA. Manejo médico de la miomatosis uterina. Revisión de la literatura. Rev Chil Obstet Ginecol 2016; 81 (1): 48-55. doi:10.4067/S0717- 75262016000100009

  37. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008; 112 (2 Pt 1): 387-400. doi: 10.1097/AOG.0b013e318183fbab

  38. Reis FM, et al. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 13-24. doi: 10.1016/j.bpobgyn.2015.11.015

  39. Islam MS, et al. Growth factors and pathogenesis. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 25-36. doi: 10.1016/j.bpobgyn.2015.08.018

  40. Van Voorhis BJ, et al. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 2002; 47: 663-9.

  41. Dueholm M, Hjorth IM. Structured imaging technique in the gynecologic office for the diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 23-43. doi: 10.1016/j.bpobgyn.2016.09.010

  42. Van den Bosch T, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015; 46 (3): 284-98. doi: 10.1002/uog.14806

  43. Parkash V, et al. Committee Opinion No. 631: Endometrial Intraepithelial Neoplasia. Obstet Gynecol 2015; 126 (4): 897. doi: 10.1097/AOG.0000000000001071

  44. Emons G, et al. New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015; 75 (2): 135-6. doi.10.1055/s-0034-1396256

  45. Adams T, Denny L. Abnormal vaginal bleeding in women with gynaecological malignancies. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 134-47. doi: 10.1016/j.bpobgyn. 2016.09.014

  46. Van Hanegem N, et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2016; 197: 147-55. doi: 10.1016/j.ejogrb.2015.12.008

  47. ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women with Postmenopausal Bleeding. Obstet Gynecol. 2018; 131(5): e124-e129. doi: 10.1097/AOG.0000000000002631.

  48. Practice bulletin no. 128: Diagnosis of Abnormal Uterine Bleeding in Reproductive-Aged Women. Obstet Gynecol.2012; 120: 197-206. doi: 10.1097/ AOG.0b013e318262e320.

  49. Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee Opinion No.580: Von Willebrand Disease in Women. Obstet Gynecol. 2013; 122: 1368-73. doi: 10.1097/01.AOG.0000438961.38979.19.

  50. Kouides PA, et al. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005; 84: 1345-51. doi: 10.1016/j. fertnstert.2005.05.035

  51. Shankar M, et al. Von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004; 111: 734-40. doi: 10.1111/j.1471-0528.2004.00176.x

  52. James AH, Kouides PA, Abdul-Kadir R, Edlund M, Federici AB, Halimeh S, et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol. 2009 Jul;201(1):12.e1-8. doi: 10.1016/j. ajog.2009.04.024

  53. Committee on Practice Bulletins—Gynecology. Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction. Obstet Gynecol. 2013 Jul;122(1):176-85. doi: 10.1097/01. doi: 10.1097/01.AOG.0000431815.52679. bb

  54. Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynecology and Obstetrics 2011; 113:3-13. doi:10.1016/j.ijgo.2010.11.011

  55. Spremović-Rađenović S, Stefanović A, Kadija S, Jeremić K, Sparić R. Classification and the diagnostics of abnormal uterine bleeding in nongravid women of reproductive age: The PALM-COEIN classification system adopted by the International Federation of Gynecology and Obstetrics. Vojnosanit Pregl. 2016;73(12):1154-9. doi: 10.2298/ VSP160709289S

  56. Madhra M, Fraser IS, Munro MG, Critchley HO. Abnormal uterine bleeding: advantages of formal classification to patients, clinicians and researchers. Acta Obstet Gynecol Scand. 2014;93(7):619-25. doi: 10.1111/aogs.12390

  57. Töz E, Sancı M, Özcan A, Beyan E, İnan AH. Comparison of classic terminology with the FIGO PALM-COEIN system for classification of the underlying causes of abnormal uterine bleeding. Int J Gynaecol Obstet. 2016;133(3):325-8. doi:10.1016/j.ijgo.2015.09.033

  58. Mishra D, Sultan S. FIGO’s PALM–COEIN Classification of Abnormal Uterine Bleeding: A Clinico-histopathological Correlation in Indian Setting The Journal of Obstetrics and Gynecology of India 2017;67(2):119–125. doi: 10.1007/ s13224-016-0925-8




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2020;88